Antidiabetic medication use during pregnancy: an international utilization study
Carolyn E. Cesta(Karolinska Institutet), Ingvild Odsbu(Norwegian Institute of Public Health), Krista F. Huybrechts(Brigham and Women's Hospital), Yongfu Yu(Fudan University), Brian T. Bateman(Stanford Medicine), Gabriella Bröms(Danderyds sjukhus), Kari Furu(Norwegian Institute of Public Health), Anna Heino(Finnish Institute for Health and Welfare), Alys Havard(UNSW Sydney), Kristjana Einarsdóttir(University of Iceland), Hanne Løvdal Gulseth, Jacqueline M. Cohen(Norwegian Institute of Public Health), Laura Pazzagli(Karolinska Institutet), Helle Kieler(Karolinska University Hospital), Maarit K. Leinonen(University of Helsinki), Helga Zoëga(University of Iceland), Øystein Karlstad(Norwegian Institute of Public Health), Sonia Hernández–Dı́az(Harvard University), Jiong Li(Unknown), Duong Thuy Tran(UNSW Sydney)
Cited by 58
Related Papers
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
|Molecular Cell|2012|3.7k
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa
|American Journal of Psychiatry|2017|603
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
|New England Journal of Medicine|2007|497